Literature DB >> 25195210

Experimental drug may change the treatment of osteoporosis. Romosozumab appears to increase bone mineral density and help rebuild the skeleton at the same time.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25195210

Source DB:  PubMed          Journal:  Duke Med Health News        ISSN: 2153-8387


× No keyword cloud information.
  1 in total

Review 1.  LRP receptor family member associated bone disease.

Authors:  N Lara-Castillo; M L Johnson
Journal:  Rev Endocr Metab Disord       Date:  2015-06       Impact factor: 6.514

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.